What do you associate with the month of May? Warmer weather, Mom, graduations, and Memorial Day? Or perhaps who seized control of the Iron Throne after eight seasons of watching Game of Thrones? For Health Law Scan, May ushered in a number of noteworthy developments, from a Supreme Court decision that expanded the ability of whistleblowers to bring False Claims Act (FCA) cases to the government’s creative uses of the Travel Act in healthcare fraud prosecutions. In between, we examined the DOJ’s criteria for cooperation credit in FCA matters and its updated guidance on what makes an effective compliance program. On the policy front, we analyzed bipartisan legislation on drug price transparency approved by the House Ways and Means Committee and efforts by the Florida legislature to deregulate healthcare. And in this month’s “Tele-Tuesday” feature, we took a closer look at the Medicare Advantage telehealth flex rule.
So if you missed a blog post, or an enticing webinar from our annual Technology May-rathon, it’s not too late to catch up:
- It’s Gonna Be May-rathon!
- LawFlash: Updated Guidance from DOJ Puts Effectiveness at Center of Corporate Compliance Programs
- Florida Legislature Moves to Deregulate Healthcare
- Fast Break on HealthTech Startups
- House Committee Approves Drug Price Transparency Legislation/Drug Sample Reporting Requirement Under Sunshine Act
- DOJ’s False Claims Act Cooperation Credit: What’s It All About?
- Tele-Tuesday: A Closer Look at the Medicare Advantage Telehealth Flex Rule
- Supreme Court Expands Whistleblower Ability to Bring FCA Cases
- The Government’s Creative Use of the Travel Act in Healthcare Fraud Prosecutions
- Healthcare Team Contributes to AHLA Health Care Compliance Legal Issues Manual
- May Fast Break Combines New Tech with Health Law
- Putting the Cart Before the Horse? The FDA’s Proposal on AI and Machine Learning Software